HVTN EOS Algorithm (visit = EOS)
Figure: HVTN EOS algorithm
ECR (EIA/CMIA/Rapid) | Geenius (assay interpretation)** | HIV-1 RNA | HIV-1 TNA(or DNA) | HIV-2 RNA | HIV-2 TNA | Unblinded EOS result summary text | |
---|---|---|---|---|---|---|---|
1 | Non-reactive x3 + NR Abbott Prism | Not required | Not required | Not required | Not required | Not required |
No evidence of infection with HIV-1 or HIV-2. No evidence of vaccine-induced sero-reactivity or serological cross-reactivity.
|
2 | Non-reactive x3 + Reactive Abbott Prism | Not required | Not required | Not required | Not required | Not required |
No evidence of infection with HIV-1 or HIV-2. No evidence of non-specific sero-reactivity or vaccine-induced sero-reactivity (if participant received vaccine product) by most recent methods available. Evidence of non-specific or possible vaccine-induced sero-reactivity by a less specific method (Abbott Prism HIV-1/2/O Plus).
|
3 | Reactive x1 or 2 or 3 |
Negative
|
Not Detected | Not Detected | Not required | Not required |
No evidence of infection with HIV-1 or HIV-2. These results are consistent with vaccine-induced sero-reactivity, if participant received vaccine product, or these results may be due to non-specific serological cross-reactivity.
|
4 | Reactive x1 or 2 or 3 |
HIV1 indeterminate or HIV1 positive (consistent with product) |
Not Detected | Not Detected | Not required | Not required |
No evidence of infection with HIV-1 or HIV-2. These results are consistent with vaccine-induced sero-reactivity, if participant received vaccine product, or these results may be due to non-specific serological cross-reactivity.
|
5 | Reactive x1 or 2 or 3 |
Negative or HIV1 indeterminate or HIV1 positive or HIV Positive, Untypable
|
Detected | Not required | Not required | Not required | Infected, HIV-1 |
6 | Reactive x1 or 2 or 3 |
Negative or HIV-1 indeterminate or HIV-1 positive or HIV Positive, Untypable
|
Not detected | Detected | Not required | Not required | Infected, HIV-1 |
7 | Reactive x1 or 2 or 3 | HIV2 Positive | Not required | Not required | Not required | Not required | Infected, HIV-2 |
8 | Reactive x1 or 2 or 3 | HIV2 indeterminate |
Not required
|
Not required |
Detected
|
Not required | Infected, HIV-2 |
9 | Reactive x1 or 2 or 3 | HIV2 indeterminate |
Not required
|
Not required | Not detected | Detected | Infected, HIV-2 |
10 | Reactive x1 or 2 or 3 | HIV Positive, Untypable | Not detected | Not detected | Detected | Not detected | Infected, HIV-2 |
11 | Reactive x1 or 2 or 3 | HIV Positive, Untypable | Not detected | Not detected | Not detected | Detected | Infected, HIV-2 |
12 | Reactive x1 or 2 or 3 | HIV Positive, Untypable |
Detected
|
Not required |
Detected
|
Not required | Infected, HIV-1 and HIV-2 |
13 | Reactive x1 or 2 or 3 | HIV Positive, Untypable | Not detected |
Detected
|
Not detected | Detected | Infected, HIV-1 and HIV-2 |
14 | Reactive x1 or 2 or 3 | HIV Positive, Untypable |
Detected
|
Not required | Not detected | Detected | Infected, HIV-1 and HIV-2 |
15 | Non-reactive x2 + Antigen reactive Abbott Determine | Negative | Not Detected | Not required | Not required | Not required | No evidence of infection with HIV-1/2 and no evidence of vaccine-induced seropositivity/reactivity (VISP/R). These results (antigen reactivity with non-detectable RNA results) are consistent with non-specific cross-reactivity (false reactive, not VISP/R). |